China Proposes Market-Oriented Pricing for Innovative Drugs to Boost High-Quality Development
The National Healthcare Security Administration (NHSA) has unveiled a draft Notification on “Establishing a Price...
Policy / Regulatory
NMPA Reports Record 61 Innovative Medical Device Approvals in 2023
The National Medical Products Administration (NMPA) has released its 2023 medical device filings work report,...
CDE Reports 35.84% Increase in Drug Filings for 2023 with Focus on Innovation and Rare Diseases
The Center for Drug Evaluation (CDE) has released its annual drug review report for 2023,...
US Senate Puts Brakes on Bill Targeting China-Based CDMOs Amid Stock Market Reactions
A US Congress bill aimed at prohibiting US-funded entities from engaging with various China-based contract...
China Reports Over 4.8 Million New Cancer Cases in 2022 Amid Rising Incidence and Mortality Rates
China’s National Cancer Center (NCC) has released the latest national cancer statistics, approved by the...
NHSA Launches Service Specifications for Medical Procurement Platform
The National Healthcare Security Administration (NHSA) has issued the “Service Specification for Medical Centralized Procurement...
China’s NHC Unveils 2024 Goals for Medical Quality and Safety Improvement
The National Health Commission (NHC) has released the “2024 National Medical Quality and Safety Improvement...
Hunan Province Hospitals Commit to Implementing Nationally Negotiated Drugs in Policy Seminar
A policy seminar under the auspices of the Hunan Healthcare Security Administration bureau convened in...
Shaanxi Province Unveils Ambitious Three-Year Plan to Boost Traditional Chinese Medicine Industry
The provincial government of Shaanxi has unveiled the “Three Year Action Plan for Empowering Shaanxi...
China-Based Biotechs Respond to US House Bill Limiting Federal Funding for ‘Concerning’ Companies
A bipartisan bill introduced on January 26, 2024, by members of the US House Select...
China’s NHC Designates 100 Areas as National Demonstration Zones for Integrated Medical and Elderly Care
The National Health Commission (NHC) has announced the selection of 100 counties (cities, districts), including...
NMPA Proposes Streamlined Market Approval Process for Domestically Produced Overseas Drugs
The National Medical Products Administration (NMPA) has released a draft proposal titled “Optimizing the Market...
NMPA Expands Generic Drug Catalog with 74th and 75th Batches for Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 74th and 75th batches of reference...
Tencent’s WeDoctor Teams Up with Guiyang for Digital Health Community Initiative
The municipal government of Guiyang has entered into a strategic partnership with WeDoctor Holdings Ltd,...
Pudong New Area Aims to Boost Healthcare with Comprehensive Reform Plan
The General Office of the CPC Central Committee and State Council has released the “Implementation...
NHC Unveils Updated Anti-Tumor Drug Guidelines for 2023 with New Drug Additions
The National Health Commission (NHC) has released the “Novel Anti-tumor Drug Clinical Application Guidelines (2023...
Shandong Province Launches Initiatives to Accelerate Pharmaceutical Innovation and Growth
Shandong province has announced a comprehensive set of measures aimed at optimizing review and approval...
Guangdong Aims to Boost Biomedicine Industry with Incentives and Strategic Development
The Guangdong Provincial Development and Reform Commission has unveiled an ambitious set of measures aimed...
Sichuan Health Commission Issues Directive to Strengthen Oversight of External Prescriptions
The Health Commission of Sichuan Province has issued a notification aimed at enhancing the management...
Hainan Province Unveils Measures to Support Innovative Drugs and Medical Devices Development
Hainan provincial bureaus, including the Healthcare Security Administration (HSA), Healthcare Commission, and Medical Products Administration,...